DNA
Price
$11.50
Change
+$0.25 (+2.22%)
Updated
Sep 26 closing price
Capitalization
680.8M
VCEL
Price
$30.23
Change
+$0.39 (+1.31%)
Updated
Sep 26 closing price
Capitalization
1.53B
40 days until earnings call
Interact to see
Advertisement

DNA vs VCEL

Header iconDNA vs VCEL Comparison
Open Charts DNA vs VCELBanner chart's image
Ginkgo Bioworks Holdings
Price$11.50
Change+$0.25 (+2.22%)
Volume$1.05M
Capitalization680.8M
Vericel
Price$30.23
Change+$0.39 (+1.31%)
Volume$881.08K
Capitalization1.53B
DNA vs VCEL Comparison Chart in %
Loading...
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNA vs. VCEL commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a StrongBuy and VCEL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (DNA: $11.50 vs. VCEL: $30.23)
Brand notoriety: DNA and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNA: 66% vs. VCEL: 118%
Market capitalization -- DNA: $680.8M vs. VCEL: $1.53B
DNA [@Biotechnology] is valued at $680.8M. VCEL’s [@Biotechnology] market capitalization is $1.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • DNA’s FA Score: 1 green, 4 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, DNA is a better buy in the long-term than VCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 3 TA indicator(s) are bullish while VCEL’s TA Score has 4 bullish TA indicator(s).

  • DNA’s TA Score: 3 bullish, 5 bearish.
  • VCEL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VCEL is a better buy in the short-term than DNA.

Price Growth

DNA (@Biotechnology) experienced а +1.14% price change this week, while VCEL (@Biotechnology) price change was -4.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

VCEL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCEL($1.53B) has a higher market cap than DNA($681M). DNA YTD gains are higher at: 17.057 vs. VCEL (-44.946). VCEL has higher annual earnings (EBITDA): 16.2M vs. DNA (-292.97M). DNA has more cash in the bank: 474M vs. VCEL (117M). VCEL has less debt than DNA: VCEL (99.8M) vs DNA (429M). VCEL has higher revenues than DNA: VCEL (249M) vs DNA (231M).
DNAVCELDNA / VCEL
Capitalization681M1.53B45%
EBITDA-292.97M16.2M-1,808%
Gain YTD17.057-44.946-38%
P/E RatioN/A215.93-
Revenue231M249M93%
Total Cash474M117M405%
Total Debt429M99.8M430%
FUNDAMENTALS RATINGS
VCEL: Fundamental Ratings
VCEL
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNAVCEL
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 22 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAPHX13.53N/A
N/A
Fidelity Healthy Future
TWEIX8.96N/A
N/A
American Century Equity Income Inv
GTSIX33.87N/A
N/A
Invesco Small Cap Growth Inv
JFACX38.50N/A
N/A
JHancock Fundamental All Cap Core R2
SSILX14.62N/A
N/A
State Street International Stock Sel A

DNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNA has been loosely correlated with RXRX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DNA jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNA
1D Price
Change %
DNA100%
+2.18%
RXRX - DNA
51%
Loosely correlated
+2.05%
ABCL - DNA
49%
Loosely correlated
+2.04%
ABSI - DNA
47%
Loosely correlated
+2.83%
CRSP - DNA
47%
Loosely correlated
+2.24%
NTLA - DNA
45%
Loosely correlated
-1.75%
More

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with CDXS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
+1.31%
CDXS - VCEL
36%
Loosely correlated
+2.50%
VNDA - VCEL
35%
Loosely correlated
+5.59%
DNA - VCEL
35%
Loosely correlated
+2.22%
PLRX - VCEL
34%
Loosely correlated
+5.56%
CRSP - VCEL
34%
Loosely correlated
+2.24%
More